Identification of a μ opiate receptor signaling mechanism in human placenta

Kirk J. Mantione, Robert M. Angert, Patrick Cadet, Richard M. Kream, George B. Stefano

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: Previous studies report that genes in the morphine biosynthetic pathway have been found in placental tissue. Prior researchers have shown that kappa opioid receptors are present in human placenta. We determined if a μ opiate receptor was present and which subtype was expressed in human placenta. We also sought to demonstrate a functional μ opiate receptor in human placenta. Material/Methods: Polymerase chain reactions as well as DNA sequencing were performed to identify the μ opiate receptor subtypes present in human placenta. The functionality of the receptor was demonstrated by real time amperometric measurements of morphine induced NO release. Results: The μ4 opiate receptor sequence was present as well as the μ1 opioid receptor transcript. The addition of morphine to placental tissue resulted in immediate nitric oxide release and this effect was blocked by naloxone. Conclusions: In the present study, an intact morphine signaling system has been demonstrated in human placenta. Morphine signaling in human placenta probably functions to regulate the immune, vascular, and endocrine functions of this organ via NO.

Original languageEnglish (US)
JournalCase Reports and Clinical Practice Review
Volume16
Issue number11
StatePublished - 2010

Fingerprint

Opioid Receptors
Placenta
Morphine
kappa Opioid Receptor
Biosynthetic Pathways
Naloxone
DNA Sequence Analysis
Blood Vessels
Nitric Oxide
Research Personnel
Polymerase Chain Reaction
Genes

Keywords

  • Endogenous morphine
  • Nitric oxide
  • Opiate receptors
  • Placenta
  • Preeclampsia

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Mantione, K. J., Angert, R. M., Cadet, P., Kream, R. M., & Stefano, G. B. (2010). Identification of a μ opiate receptor signaling mechanism in human placenta. Case Reports and Clinical Practice Review, 16(11).

Identification of a μ opiate receptor signaling mechanism in human placenta. / Mantione, Kirk J.; Angert, Robert M.; Cadet, Patrick; Kream, Richard M.; Stefano, George B.

In: Case Reports and Clinical Practice Review, Vol. 16, No. 11, 2010.

Research output: Contribution to journalArticle

Mantione, KJ, Angert, RM, Cadet, P, Kream, RM & Stefano, GB 2010, 'Identification of a μ opiate receptor signaling mechanism in human placenta', Case Reports and Clinical Practice Review, vol. 16, no. 11.
Mantione, Kirk J. ; Angert, Robert M. ; Cadet, Patrick ; Kream, Richard M. ; Stefano, George B. / Identification of a μ opiate receptor signaling mechanism in human placenta. In: Case Reports and Clinical Practice Review. 2010 ; Vol. 16, No. 11.
@article{cfdf0fc4514e4cd2bbc60c7fcddfaf43,
title = "Identification of a μ opiate receptor signaling mechanism in human placenta",
abstract = "Background: Previous studies report that genes in the morphine biosynthetic pathway have been found in placental tissue. Prior researchers have shown that kappa opioid receptors are present in human placenta. We determined if a μ opiate receptor was present and which subtype was expressed in human placenta. We also sought to demonstrate a functional μ opiate receptor in human placenta. Material/Methods: Polymerase chain reactions as well as DNA sequencing were performed to identify the μ opiate receptor subtypes present in human placenta. The functionality of the receptor was demonstrated by real time amperometric measurements of morphine induced NO release. Results: The μ4 opiate receptor sequence was present as well as the μ1 opioid receptor transcript. The addition of morphine to placental tissue resulted in immediate nitric oxide release and this effect was blocked by naloxone. Conclusions: In the present study, an intact morphine signaling system has been demonstrated in human placenta. Morphine signaling in human placenta probably functions to regulate the immune, vascular, and endocrine functions of this organ via NO.",
keywords = "Endogenous morphine, Nitric oxide, Opiate receptors, Placenta, Preeclampsia",
author = "Mantione, {Kirk J.} and Angert, {Robert M.} and Patrick Cadet and Kream, {Richard M.} and Stefano, {George B.}",
year = "2010",
language = "English (US)",
volume = "16",
journal = "American Journal of Case Reports",
issn = "1941-5923",
publisher = "International Scientific Literature, Inc",
number = "11",

}

TY - JOUR

T1 - Identification of a μ opiate receptor signaling mechanism in human placenta

AU - Mantione, Kirk J.

AU - Angert, Robert M.

AU - Cadet, Patrick

AU - Kream, Richard M.

AU - Stefano, George B.

PY - 2010

Y1 - 2010

N2 - Background: Previous studies report that genes in the morphine biosynthetic pathway have been found in placental tissue. Prior researchers have shown that kappa opioid receptors are present in human placenta. We determined if a μ opiate receptor was present and which subtype was expressed in human placenta. We also sought to demonstrate a functional μ opiate receptor in human placenta. Material/Methods: Polymerase chain reactions as well as DNA sequencing were performed to identify the μ opiate receptor subtypes present in human placenta. The functionality of the receptor was demonstrated by real time amperometric measurements of morphine induced NO release. Results: The μ4 opiate receptor sequence was present as well as the μ1 opioid receptor transcript. The addition of morphine to placental tissue resulted in immediate nitric oxide release and this effect was blocked by naloxone. Conclusions: In the present study, an intact morphine signaling system has been demonstrated in human placenta. Morphine signaling in human placenta probably functions to regulate the immune, vascular, and endocrine functions of this organ via NO.

AB - Background: Previous studies report that genes in the morphine biosynthetic pathway have been found in placental tissue. Prior researchers have shown that kappa opioid receptors are present in human placenta. We determined if a μ opiate receptor was present and which subtype was expressed in human placenta. We also sought to demonstrate a functional μ opiate receptor in human placenta. Material/Methods: Polymerase chain reactions as well as DNA sequencing were performed to identify the μ opiate receptor subtypes present in human placenta. The functionality of the receptor was demonstrated by real time amperometric measurements of morphine induced NO release. Results: The μ4 opiate receptor sequence was present as well as the μ1 opioid receptor transcript. The addition of morphine to placental tissue resulted in immediate nitric oxide release and this effect was blocked by naloxone. Conclusions: In the present study, an intact morphine signaling system has been demonstrated in human placenta. Morphine signaling in human placenta probably functions to regulate the immune, vascular, and endocrine functions of this organ via NO.

KW - Endogenous morphine

KW - Nitric oxide

KW - Opiate receptors

KW - Placenta

KW - Preeclampsia

UR - http://www.scopus.com/inward/record.url?scp=79951568816&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951568816&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:79951568816

VL - 16

JO - American Journal of Case Reports

JF - American Journal of Case Reports

SN - 1941-5923

IS - 11

ER -